×

Archive The Faber Report

  Friday, 24 Oct 2014 | 9:38 AM ET

Chiquita shareholders reject Fyffes transaction

Posted ByDavid Faber
CNBC's Dominic Chu reports Chiquita shareholders have rejected the company's proposed merger with Fyffes. »Read more
  Friday, 17 Oct 2014 | 9:42 AM ET

Faber Report: Allergan takeover battle

Posted ByDavid Faber
CNBC's David Faber reports Valeant will not raise its bid for Allergan before the October 30th record date, and will likely raise the bid prior to the December 18th meeting. »Read more
  Wednesday, 15 Oct 2014 | 10:09 AM ET

Faber Report: AbbVie's rethink bad for hedge funds?

Posted ByDavid Faber
CNBC's David Faber reports AbbVie will have a meeting on October 20th to make a decision on the potential acquisition of Shire plc. Faber looks at the hedge funds that own Shire. »Read more
  Monday, 13 Oct 2014 | 9:38 AM ET

Faber Report: Hedge fund pain

Posted ByDavid Faber
CNBC's David Faber discusses reasons for the decline in hedge fund stocks. »Read more
  Friday, 10 Oct 2014 | 9:42 AM ET

Faber Report: Media stocks slide

Posted ByDavid Faber
CNBC's David Faber discusses the challenges facing traditional cable providers and the slide of media stocks on ratings and advertising concerns. »Read more
  Thursday, 9 Oct 2014 | 9:40 AM ET

Faber Report: Allergan updates guidance

Posted ByDavid Faber
CNBC's David Faber reports Allergan has released new guidance and has raised its earnings outlook. »Read more
  Thursday, 9 Oct 2014 | 9:32 AM ET

Endo buys Auxilium Pharma

Posted ByDavid Faber
CNBC's David Faber reports Auxilium Pharma has agreed to be purchased by Endo International in a cash and stock transaction. »Read more
  Wednesday, 8 Oct 2014 | 9:46 AM ET

Elliott goes public on EMC position: Faber

Posted ByDavid Faber
CNBC's David Faber reports the details of Elliott Management's letter to EMC about spinning off VMware, and explains Hewlett-Packard's interest in EMC. »Read more
  Wednesday, 8 Oct 2014 | 9:38 AM ET

Faber Report: Allergan news & noise

Posted ByDavid Faber
CNBC's David Faber reports the latest on Valeant's bid for Allergan, and how Actavis pushed Valeant to raise their bid. »Read more
  Wednesday, 1 Oct 2014 | 9:39 AM ET

Faber Report: Fannie & Freddie

Posted ByDavid Faber
CNBC's David Faber reports the court has thrown out investor lawsuits related to Fannie and Freddie profits. »Read more